Mitchells & Butlers Says Year To Date Total Sales At 45% Of Pre-Covid Levels

Mitchells & Butlers Plc (MAB.L,MLB), in its trading statement covering the 51 weeks ended 18 September 2021, said that total sales year to date, including 18 weeks of enforced closurea, were at 45% of pre-Covid levels.

As at 18 September the Group had cash balances on hand of 197 million pounds, with undrawn unsecured facilities of 150 million pounds. The Liquidity Facility is now fully repaid within the securitisation.

In the 18 weeks since full indoor trading reopened on 17 May like-for-like sales have been 97% of pre-Covid levels, following an improvement since the last update in the most recent 8 weeks to 104%.

The company noted that trading continues to be stronger in suburban and food-led brands, particularly at the more premium end of the market.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Mukilteo, Washington-based Ivar's Soup and Sauce Co. is recalling 14,968 sleeves of refrigerated Kettle Classic Clam Chowder With Uncured Bacon citing the possible presence of hard, sharp opaque plastic pieces, the U.S Foof and Drug Administration said. The products were sold exclusively at Costco stores. The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's top-selling drug Humira or adalimumab. Cyltezo, originally approved in August 2017, is both biosimilar to, and interchangeable with Humira for Cyltezo's approved uses. The Food and Drug Administration may be planning to allow people to receive Covid-19 vaccine booster shot that is different from the initial dose, reports indicate. The agency is likely to make the announcement on mix and match approach on coronavirus booster vaccines on Wednesday. The move will be part of FDA's expected authorization of boosters for the Moderna and Johnson & Johnson vaccines.
Follow RTT